Cyclodextrins in ophthalmic drug delivery

被引:250
|
作者
Loftssona, T
Järvinen, T
机构
[1] Univ Iceland, Dept Pharm, IS-18127 Reykjavik, Iceland
[2] Univ Kuopio, Dept Pharmaceut Chem, FIN-70211 Kuopio, Finland
基金
芬兰科学院;
关键词
corneal permeability; eye; ocular absorption; ocular irritation; penetration enhancer; solubility; stability; topical administration; water-soluble polymer;
D O I
10.1016/S0169-409X(98)00055-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Most ocular diseases are treated by topical drug application in the form of aqueous eye drop solutions. Recent studies have shown that cyclodextrins are useful additives in ophthalmic formulations for increasing the aqueous solubility, aqueous stability and bioavailability of ophthalmic drugs, and to decrease drug irritation. However, these studies have also shown that there are some basic differences between ophthalmic administration of cyclodextrins and administration of cyclodextrins via other routes. These differences have induced some limitations in the ophthalmic application of these most recently developed pharmaceutical excipients. The objective of this review is to summarize recent findings and applications of various cyclodextrins in ophthalmic drug delivery. Their mechanism of action in aqueous eye drop formulations is also discussed. Finally, the formulation of a couple of cyclodextrin containing eye drop solutions is described. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:59 / 79
页数:21
相关论文
共 50 条
  • [1] Problems in Ophthalmic Drug Delivery: Evaluation of the Interaction Between Preservatives and Cyclodextrins
    Malaekeh-Nikouei, Bizhan
    Bazzaz, Bibi Sedigheh Fazly
    Soheili, Vahid
    Mohammadian, Kobra
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2013, 6 (05)
  • [2] Cyclodextrins for drug delivery
    Laza-Knoerr, A. L.
    Gref, R.
    Couvreur, P.
    JOURNAL OF DRUG TARGETING, 2010, 18 (09) : 645 - 656
  • [3] Cyclodextrins in drug delivery systems
    Otero-Espinar, F. J.
    Torres-Labandeira, J. J.
    Alvarez-Lorenzo, C.
    Blanco-Mendez, J.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2010, 20 (04) : 289 - 301
  • [4] Cyclodextrins in nasal drug delivery
    Merkus, FWHM
    Verhoef, JC
    Marttin, E
    Romeijn, SG
    van der Kuy, PHM
    Hermens, WAJJ
    Schipper, NGM
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) : 41 - 57
  • [5] OPHTHALMIC DRUG DELIVERY SYSTEMS
    SHELL, JW
    SURVEY OF OPHTHALMOLOGY, 1984, 29 (02) : 117 - 128
  • [6] OPHTHALMIC DRUG DELIVERY SYSTEMS
    SHELL, JW
    DRUG DEVELOPMENT RESEARCH, 1985, 6 (03) : 245 - 261
  • [7] Advances in ophthalmic drug delivery
    Morrison, Peter W. J.
    Khutoryanskiy, Vitaliy V.
    THERAPEUTIC DELIVERY, 2014, 5 (12) : 1297 - 1315
  • [8] Advances in ophthalmic drug delivery
    Singh, Thakur Raghu Raj
    Jones, David
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2014, 66 (04) : 487 - 489
  • [9] Nanospheres for ophthalmic drug delivery
    Crawford, KS
    Koroskenyi, B
    Ruggiero, AL
    Jahngen, EGE
    McCarthy, SP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [10] Biomaterials in ophthalmic drug delivery
    Sintzel, MB
    Bernatchez, SF
    Tabatabay, C
    Gurny, R
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1996, 42 (06) : 358 - 374